Insights

Mergers & Acquisitions Potential With recent mergers involving Shire, Takeda, and Baxalta, there may be opportunities for cross-selling or partnership discussions with the new entities formed through these acquisitions.

Research Collaboration Baxalta's focus on investing in assets like the AAV8 vector and launching numerous clinical trials indicates a commitment to innovation. Exploring collaborative research projects or licensing agreements could lead to sales opportunities.

Product Differentiation Strategy The launch of products like CUVITRU and the development of Adynovate® demonstrate Baxalta's capability in bringing unique therapies to market. Tailoring sales pitches to highlight these differentiated products can attract niche market segments.

Legal Partnerships The legal disputes with Bayer AG over patent infringement highlight the importance of solid legal partnerships. Offering legal services or solutions to mitigate risks related to intellectual property could be a valuable sales proposition.

Market Expansion Opportunities With a revenue of over $1 billion and a focus on biotechnology research, Baxalta presents an attractive market for companies seeking to expand into the biotech industry. Exploring partnership or acquisition opportunities could lead to sales growth in this sector.

Baxalta Tech Stack

Media & News

Baxalta's Email Address Formats

Baxalta uses at least 1 format(s):
Baxalta Email FormatsExamplePercentage
first.last@baxalta.comJohn.Doe@baxalta.com
97%
lastf@baxalta.comDoeJ@baxalta.com
2%
flast@baxalta.comJDoe@baxalta.com
1%
first.middle@baxalta.comJohn.Michael@baxalta.com
0%

Frequently Asked Questions

Where is Baxalta's headquarters located?

Minus sign iconPlus sign icon
Baxalta's main headquarters is located at Northern Illinois, US. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Baxalta's phone number?

Minus sign iconPlus sign icon
You can contact Baxalta's main corporate office by phone at +1-888-237-7684. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Baxalta's stock symbol?

Minus sign iconPlus sign icon
Baxalta is a publicly traded company; the company's stock symbol is BXLT.

What is Baxalta's official website and social media links?

Minus sign iconPlus sign icon
Baxalta's official website is baxalta.com and has social profiles on LinkedIn.

How much revenue does Baxalta generate?

Minus sign iconPlus sign icon
As of June 2024, Baxalta's annual revenue reached $501B.

What is Baxalta's SIC code NAICS code?

Minus sign iconPlus sign icon
Baxalta's SIC code is 2836 - Biological Products, Except Diagnostic Substances NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Baxalta have currently?

Minus sign iconPlus sign icon
As of June 2024, Baxalta has approximately 521 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: K. N.Vice President Environment Health And Safety: D. D.Head Of Supply Chain, Great China: D. L.. Explore Baxalta's employee directory with LeadIQ.

What industry does Baxalta belong to?

Minus sign iconPlus sign icon
Baxalta operates in the Biotechnology Research industry.

What is Baxalta's email format?

Minus sign iconPlus sign icon
Baxalta's email format typically follows the pattern of . Find more Baxalta email formats with LeadIQ.

When was Baxalta founded?

Minus sign iconPlus sign icon
Baxalta was founded in 2015.
Baxalta

Baxalta

Biotechnology ResearchIllinois, United States10001+ Employees

Shire acquired Baxalta on June 3, 2016. Following this date, this page will no longer be actively monitored. There will be no updates or responses posted on this page.  For continued news and updates, we encourage you to follow Shire on LinkedIn at https://www.linkedin.com/company/shire

Section iconCompany Overview

Headquarters
Northern Illinois, US
Phone number
+1-888-237-7684
SIC Code
2836 - Biological Products, Except Diagnostic Substances
Stock Symbol
BXLT
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
10001+

Section iconFunding & Financials

  • $1B

    Baxalta's revenue is in the range of $1B

Section iconFunding & Financials

  • $1B

    Baxalta's revenue is in the range of $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.